Site-Specific Integration of TRAIL in iPSC-Derived Mesenchymal Stem Cells for Targeted Cancer Therapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Site-Specific Integration of TRAIL in iPSC-Derived Mesenchymal Stem Cells for Targeted Cancer Therapy
Authors
Keywords
-
Journal
Stem Cells Translational Medicine
Volume 11, Issue 3, Pages 297-309
Publisher
Oxford University Press (OUP)
Online
2022-01-01
DOI
10.1093/stcltm/szab031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mesenchymal stem cells derived from iPSCs expressing interleukin-24 inhibit the growth of melanoma in the tumor-bearing mouse model
- (2020) Zheng Wu et al. Cancer Cell International
- TRAIL in oncology: From recombinant TRAIL to nano- and self-targeted TRAIL-based therapies
- (2020) Hassan Dianat-Moghadam et al. PHARMACOLOGICAL RESEARCH
- Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery
- (2020) Graça Almeida-Porada et al. Molecular Therapy-Methods & Clinical Development
- Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy
- (2020) Abdelkrim Hmadcha et al. Frontiers in Bioengineering and Biotechnology
- Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature
- (2019) Lucas-Sebastian Spitzhorn et al. Stem Cell Research & Therapy
- Manufacturing of primed mesenchymal stromal cells for therapy
- (2019) James Q. Yin et al. Nature Biomedical Engineering
- Production of Mesenchymal Stem Cells Through Stem Cell Reprogramming
- (2019) Ahmed Abdal Dayem et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour
- (2018) Kamal Shaik Fakiruddin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
- (2018) Ioannis Christodoulou et al. Stem Cell Research & Therapy
- Enhanced tumor growth inhibition by mesenchymal stem cells derived from iPSCs with targeted integration of interleukin24 into rDNA loci
- (2017) Bo Liu et al. Oncotarget
- Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells
- (2017) Wen-Xiang Gao et al. Stem Cell Research & Therapy
- hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine
- (2016) Vikram Sabapathy et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- TRAIL Based Therapy: Overview of Mesenchymal Stem Cell Based Delivery and miRNA Controlled Expression of TRAIL
- (2014) Rukset Attar et al. Asian Pacific Journal of Cancer Prevention
- TALE nickase mediates high efficient targeted transgene integration at the human multi-copy ribosomal DNA locus
- (2014) Yong Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs
- (2014) Qingguo Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies
- (2012) C. T. Hellwig et al. MOLECULAR CANCER THERAPEUTICS
- Targeting of the Human Coagulation Factor IX Gene at rDNA Locus of Human Embryonic Stem Cells
- (2012) Xionghao Liu et al. PLoS One
- Targeting the extrinsic apoptosis signaling pathway for cancer therapy
- (2011) Thomas J. Sayers CANCER IMMUNOLOGY IMMUNOTHERAPY
- Concise Review: Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells: Progress Toward Safe Clinical Products
- (2011) Yunjoon Jung et al. STEM CELLS
- Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer
- (2010) Roy S. Herbst et al. JOURNAL OF CLINICAL ONCOLOGY
- Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer
- (2009) M. R. Loebinger et al. CANCER RESEARCH
- Progress and prospects: immune responses to viral vectors
- (2009) S Nayak et al. GENE THERAPY
- Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model
- (2008) Andrea Mohr et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now